BILL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BILL Holdings Inc is not a strong buy for a beginner investor with a long-term strategy at this time. The stock is currently facing bearish technical indicators, weak financial performance, and mixed analyst sentiment. While hedge funds are increasing their positions, the lack of significant positive catalysts and recent price target reductions suggest a cautious approach. Holding off on investing until clearer positive trends emerge is advisable.
The technical indicators for BILL are bearish. The MACD is negatively expanding, RSI is neutral at 28.995, and moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 38.035), with resistance levels at R1: 41.435 and R2: 42.485. The stock has a 70% chance of declining further in the short term (-1.94% in the next day, -2.19% in the next week, and -3.32% in the next month).
Hedge funds have increased their buying activity by 111.02% over the last quarter. Analysts from Truist and Canaccord recently raised their price targets, citing higher net adds, improved volume per customer, and business momentum. Additionally, there is speculation about potential acquisition interest, which could drive the stock higher in the future.
The company's financial performance in Q2 2026 was weak, with net income dropping by -107.71% YoY and EPS declining by -109.38% YoY. Gross margin also fell by -2.06% YoY. Analysts from Goldman Sachs, Keefe Bruyette, Evercore ISI, BMO Capital, and Baird have all lowered their price targets recently. Technical indicators are bearish, and the stock is likely to decline further in the short term. Insider trading activity is neutral, and there is no recent congress trading data to indicate confidence from influential figures.
In Q2 2026, BILL Holdings reported revenue growth of 14.37% YoY to $414.67 million. However, net income dropped significantly to -$2.59 million (-107.71% YoY), and EPS declined to -$0.03 (-109.38% YoY). Gross margin also decreased slightly to 77.82% (-2.06% YoY), indicating challenges in profitability despite revenue growth.
Analyst sentiment is mixed. While Truist and Canaccord raised their price targets to $59 and $77, respectively, Goldman Sachs, Keefe Bruyette, Evercore ISI, BMO Capital, and Baird have all lowered their targets. The consensus among analysts is cautious optimism, with several maintaining Buy ratings but emphasizing the need for sustained performance improvements.
